Quick Answer
HERON THERAPEUTICS, INC. /DE/ reported Total Assets of $255.88 million for fiscal year 2025.
HERON THERAPEUTICS, INC. /DE/ Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $255.88M | +9.7% |
| 2024 | $233.15M | +4.8% |
| 2023 | $222.51M | -11.3% |
| 2022 | $250.95M | -17.9% |
| 2021 | $305.71M | -13.5% |
| 2020 | $353.56M | -31.1% |
| 2019 | $512.78M | +10.9% |
| 2018 | $462.18M | +97.3% |
| 2017 | $234.31M | +247.2% |
| 2016 | $67.48M | -51.0% |
| 2015 | $137.84M | +79.8% |
| 2014 | $76.68M | +1.0% |
| 2013 | $75.94M | +35.7% |
| 2012 | $55.97M | +187.8% |
| 2011 | $19.45M | +568.0% |
| 2010 | $2.91M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $248.95M | +12.8% | +7.3% |
| June 30, 2025 | $232.09M | +6.4% | -1.6% |
| March 31, 2025 | $235.75M | +8.2% | +1.1% |
| December 31, 2024 | $233.15M | +4.8% | +5.6% |
| September 30, 2024 | $220.78M | -3.7% | +1.2% |
| June 30, 2024 | $218.14M | +8.4% | +0.1% |
| March 31, 2024 | $217.89M | -1.4% | -2.1% |
| December 31, 2023 | $222.51M | -11.3% | -2.9% |
- HERON THERAPEUTICS, INC. /DE/ showed an increase of +9.7% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, HERON THERAPEUTICS, INC. /DE/’s total assets has grown by 8690.0% (from $2.91 million to $255.88 million).
- The most recent figure is from HERON THERAPEUTICS, INC. /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: